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BRIEF RESEARCH REPORTRat model of cardiopulmonary bypass for deep hypothermic
circulatory arrestTomWaterbury, MPS, CCP, LP, Thomas J. Clark, BS, Scott Niles, BS, and Robert Saeid Farivar, MD, PhD,
Iowa City, IowaLarge animal cardiopulmonary bypass (CPB) models have
disadvantages, such as cost, lack of methods for assessment
of neurocognitive function, and difficulties with long-term
recovery. As a result, rodent models have been devel-
oped.1-4 Previous rodent models have certain drawbacks,
including irrelevance to human flows used clinically. We
established a clinically relevant model of CPB with deep
hypothermic circulatory arrest (DHCA) in the rat. Our
CPB circuit has several novel features, including a small
priming volume, active cooling/rewarming processes,
vacuum-assisted venous drainage, peripheral cannulation
without thoracotomy or sternotomy, and an accurate means
of monitoring peripheral tissue oxygenation. This small an-
imal model provides a simple experimental system that
could be used in future studies that use CPB and DHCA.MATERIALS AND METHODS
Animal Model
The University of Iowa Institutional Animal Care and Use Committee
approved this study. Fifteen Sprague–Dawley rats (350–450 g) fromCharles
River Laboratories (Wilmington, Mass) were housed under standard condi-
tions. Nonfasted rats were anesthetized with chloral hydrate and isoflurane
in 60% oxygen. During surgical preparation and recovery, anesthesia was
maintained with isoflurane. Rats were allowed to spontaneously breathe
air with an inspired oxygen fraction of 100%. After the start of CPB, the
oxygenator gas flow rate was held between 1 and 2.5 L/min to maintain
blood gases within the physiologic range. Animals were not intubated.
Surgical preparation consisted of cannulation of the left femoral artery
for arterial inflow with a 20-gauge Angiocath catheter (Becton Dickinson,
Franklin Lakes, NJ) and the right femoral artery for blood pressure moni-
toring with a 22-gauge Angiocath catheter via a cutdown. An injection of
400 IU/kg of porcine heparin was given after placement of the first catheter,
and activated clotting time was maintained above 500 during CPB. The
right common jugular vein was cannulated with a modified 4-hole
16-gauge Angiocath catheter that was advanced into the right atrium for
venous drainage. A vacuum regulator with an applied pressure of
30 mm H2O was developed to facilitate increased venous drainage.
A rectal temperature of 18Cwas achieved over 40minutes, using CPB-
assisted cooling. At this temperature, rats still had a heart rate in the 30s. If
the heart rate was not 0, we further cooled to cardiac arrest by echocardio-
gram (typically 14C). After reaching arrest, the circuit was turned off and
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The Journal of Thoracic and Car34C to 35C over a period of 36 to 42 minutes using CPB-assisted re-
warming, a heating blanket, and a heating lamp. The temperature gradient
between the CPB circuit and body core did not exceed 10C. Simulta-
neously, 0.1 mEq of sodium bicarbonate and 0.14 mEq of calcium chloride
were administered. After full rewarming, the remaining priming volume
was reinfused and animals were weaned from CPB.
Physiologic Parameter Measurement and Analysis
The core and circuit temperature were continuously monitored with
a dual temperature monitor (Figure 1, A) (DeBusk Temperature Systems;
DeRoyal Technologies, Inc, New Tazewell, Tenn). An iStat Analyzer (Ab-
bott Point of Care; Abbott Laboratories, Abbott Park, Ill) was used to an-
alyze arterial blood gases (a-stat method), hemoglobin, and hematocrit.
Samples were taken at baseline, 27C, and 18C during the cooling stage
(approximately 20 and 40minutes, respectively) and at 27C and 34C dur-
ing the rewarming stage (approximately 60 and 80 minutes, respectively).
The DHCA duration was excluded from aforementioned time. During
CPB, the blood flow and venous saturation were continuously monitored.
Targeted CPB flow was 100 to 120 mL $ kg1 $ min1, corresponding to
about 70% of normal cardiac output.
Experimental Circuitry
The CPB circuit (shown in entirety in Figure 1) was primed with 12 mL
of Plasma-Lyte solution (Baxter Healthcare, Deerfield, Ill) and consisted of
the following components:
 Venous reservoir (Figure 1, F), connected to vacuum regulator (Ohmeda;
Ohio Medical Corporation, Gurnee, Ill)
 Peristaltic pump (Figure 1, C) (Masterflex; Cole-Parmer, Vernon Hills,
Ill)
 Heat exchanger (Figure 1,E) (Sarns cardioplegic set; Terumo Cardiovas-
cular Systems, Ann Arbor, Mich)
 Specifically designed rodent membrane oxygenator (Figure 1, D) (Arte-
riocyte, Cleveland, Ohio). The membrane oxygenator is constructed
from 2 Plexiglas shells (Rohm and Haas Company, Philadelphia, Pa),
which carry the diffusion membrane. The diffusion membrane is
composed of 3 layers of polypropylene hollow-fiber mats (Jostra AG,
Hirrlingen, Germany) fused in a crosswise fashion to improve oxygena-
tion. The membrane has a gas exchange area of 558 cm2 and a priming
volume of 4 mL.
 Ultrasound flowmeter (Figure 1, B) (2N806 flow probe and T208 volume
flowmeter; Transonic Systems, Ithaca, NY)
 Mixed venous oximeter (Oximetrix 3, Abbott Critical Care Systems)
 Silicone tubing with a 1.6-mm internal diameter (Cole-Parmer
Instruments)RESULTS
Fifteen rats were used for analysis. The average values of
physiologically relevant parameters, taken immediately be-
fore the initiation of the cooling process (baseline) and at
various stages of the procedure (ie, during cooling at 20
and 40 minutes and during rewarming at 60 and 80 minutes)
are shown in Table 1.
Rats were typically cooled to 14C to 18C until com-
plete arrest. The duration of DHCA was excluded fromdiovascular Surgery c Volume 141, Number 6 1549
FIGURE 1. Cardiopulmonary bypass circuit: A, temperature monitor; B, ultrasonic flowmeter; C, roller pump; D, membrane oxygenator; E, heat
exchanger; F, venous reservoir; G, arterial line; and H, venous line.
Brief Research Reportdata analysis (15 minutes). Owing to hemodilution, some
rats demonstrated a low mean arterial pressure and hemo-
globin concentration as compared with baseline values.
The mean arterial pressure dropped 20 points (on average)
at the beginning of CPB but was subsequently maintained
above 50 mm Hg via epinephrine injection. Typically, dur-
ing rewarming, mean arterial pressure remained above
50 mm Hg without the use of inotropic agents. Lidocaine
2 mg and calcium chloride 0.14 mEq were routinely admin-
istered during rewarming. If animals had a pH less than 7.0,
they received sodium bicarbonate 0.1 mEq.TABLE 1. Physiologically relevant parameters of rats undergoing CPB w
Time
Baseline
0 min
Cooling
20 min
Hemoglobin (g/dL) 13.3 (1.4) 7.3 (1.3)
Hematocrit 39.7 (3.9) 21.8 (3.7)
Flow (mL/min) 49.1 (7.5) 40.6 (12.5)
Temperature (C) 33.8 (0.8) 27.1 (1.6)
Heart rate 185.4 (43.3) 56.5 (18.7)
MAP 69.9 (20.1) 49.8 (18.3)
pH 7.15 (0.12) 7.12 (0.11)
PCO2 52.3 (20.0) 46.9 (9.9)
PO2 184.8 (128.0) 111.2 (73.2)
HCO3
 18.7 (4.8) 15.8 (2.9)
Base excess 11.4 (3.8) 12.3 (4.2)
SaO2 95.3 (5.4) 87.6 (11.8)
MVO2 64.8 (18.5) 61.9 (15.7)
CPB, Cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest.Mean and (sta
ature, heart rate, mean arterial pressure (MAP), pH, carbon dioxide tension (PCO2), oxyg
saturation (SaO2), and mixed venous (MVO2) oxygen saturation. These were measured at
27C, and 17C. DHCA duration was 15 minutes, then after 20 and 40 minutes (labeled 6
1550 The Journal of Thoracic and Cardiovascular SurDISCUSSION
We established a small animal model of CPB with
DHCA in the rat. Our circuit has several innovative ele-
ments, including vacuum-assisted venous drainage, periph-
eral cannulation (without thoracotomy or sternotomy),
active heating and cooling with a heat exchanger, a novel
small membrane oxygenator, lack of need for intubation,
a venous oximeter, and ultrasound flowmeter. With all these
modifications, we were able to achieve 100 to 150-mL $
kg1 $ min1 flow, which is relevant to clinically used
CPB circuits.ith DHCA (n ¼ 15)
Rewarming
40 min 60 min 80 min
6.6 (0.9) 6.3 (1.1) 6.3 (0.8)
19.6 (3.2) 18.9 (3.6) 18.6 (3.2)
39.7 (14.7) 51.7 (14.8) 46.6 (11.7)
17.9 (0.7) 27.8 (3.2) 35.5 (0.8)
23 (4.8) 149.8 (42.9) 190.9 (41.3)
51 (16.1) 61.8 (15.3) 59.8 (7.4)
7.14 (0.08) 7.18 (0.14) 7.15 (0.14)
43.0 (7.1) 44.25 (17.2) 43.3 (15.4)
187.5 (103.7) 98 (32.9) 88.41 (31.3)
15.5 (3.5) 17.9 (7.6) 15.6 (6.9)
13.4 (5.3) 9.1 (8.4) 11.7 (8.8)
96.9 (2.6) 92.1 (3.9) 90.2 (6.1)
72 (12.3) 56.1 (13.9) 50.6 (13.1)
ndard deviation) for Hemoglobin, hematocrit, flow through the pump, rectal temper-
en tension (PO2), and bicarbonate (HCO3
), as well as base excess, arterial oxygen
time 0, as well as 20 and 40 minutes into cooling, which corresponded with 37C,
0 min and 80 min, respectively).
gery c June 2011
Brief Research ReportMiniaturization of the membrane oxygenator represents
the major limiting factor in the creation of a successful
CPB model in small animals. Previous models have re-
quired high priming volumes to achieve acceptable hemat-
ocrit concentrations during the experiment. Our study uses
a miniature novel oxygenator, modified venous cannula
design, and reduction in the length of connection tubing,
which allowed minimization of the priming volume, thus
improving postoperative outcomes.
This model was developed to study neurocognitive
models after DHCA. Thus, peripheral cannulation instead
of thoracotomy or sternotomy is desired. Endotracheal in-
tubation with mechanical ventilation was not performed.
The absence of mechanical ventilation helped prevent the
hypotension and bradycardia commonly observed at cessa-
tion of ventilation during CPB. Vacuum-assisted venous
drainage, along with careful positioning of the venous
outflow catheter, allowed an optimal venous drainage and
provided an adequate perfusion flow rate of 100 to
120 mL $ kg1 $ min1, which is comparable with human
flows. Ready access to femoral arteries reduced surgical
trauma and resulted in decreased blood loss, in additionThe Journal of Thoracic and Carto better perfusion flow as compared with cannulation of
the tail artery.
Full cardiac arrest was achieved at 14C in all animals.
Whereas others have used 9 mg of esmolol and 0.2 mEq
of potassium chloride to reach cardiac arrest,4 we managed
to achieve cardiac arrest with cooling alone (at a tempera-
ture of 15.7C  0.4C).
Certain limitations to this study remain, such as the ab-
sence of monitoring of pericranial temperature. Future mod-
ifications include the use of a hemoconcentrator to improve
hematocrit. We will use this model in future studies to assess
the neuroprotective effects of smallmolecules duringDHCA.
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